Parthenon and ImaginAb enter into license and supply agreement for anti-cancer therapies
Precision oncology company, Parthenon Therapeutics, and ImaginAb Inc., a global biotech have entered into a…
November 10, 2022 - 4 minutes
Precision oncology company, Parthenon Therapeutics, and ImaginAb Inc., a global biotech have entered into a…